SF3B1 and B-cell chronic lymphocytic leukemia: In the MEC-1 cell line, which contains the pre-existing del(17p) genetic lesion, amplification at chromosome 7q22.1 stood as the most significant CNV event shared with patients with primary CLL harboring both SF3B1 mutation and del(17p) (Fig. 4F).